However, it has been reported that patients with high ALG13 expression had longer OS than those with low expression in non-small-cell lung cancer43, and ALG13 mutations in uterine corpus endometrial carcinoma were linked with better survival (p = 0.01)44. Here, ALG13 is linked to uterine corpus endometrial carcinoma.